Human Mast Cells Produce and Differentially Express Both Soluble and Membrane‐Bound Stem Cell Factor
暂无分享,去创建一个
[1] W. Danho,et al. High Affinity Human IgE Receptor (FcrRI) ANALYSIS OF FUNCTIONAL DOMAINS OF THE a-SUBUNIT WITH MONOCLONAL ANTIBODIES , 2001 .
[2] E. Arbustini,et al. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. , 1998, Circulation.
[3] Henz Bm. SCF and c-kit in mastocytosis--a Pandora's box holding more theories than proven facts. , 1998 .
[4] Möller,et al. Comparative cytokine gene expression: regulation and release by human mast cells , 1998, Immunology.
[5] B. Henz. SCF and c-kit in mastocytosis--a Pandora's box holding more theories than proven facts. , 1998, The Journal of investigative dermatology.
[6] R. Halaban,et al. Chymase cleavage of stem cell factor yields a bioactive, soluble product. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] B. Longley,et al. Human skin/SCID mouse chimeras as an in vivo model for human cutaneous mast cell hyperplasia. , 1997, The Journal of investigative dermatology.
[8] G. Marone,et al. Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy , 1997, Inflammation Research.
[9] E. Fiebiger,et al. Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. , 1996, The Journal of investigative dermatology.
[10] U. Lippert,et al. Production of interleukin-6 by human mast cells and basophilic cells. , 1996, The Journal of investigative dermatology.
[11] B. Czarnetzki,et al. Expression of stem cell factor in cutaneous mastocytosis , 1995, The British journal of dermatology.
[12] D. Metcalfe,et al. Mast cell ontogeny and apoptosis , 1995, Experimental dermatology.
[13] G. Nilsson,et al. Stem cell factor is a chemotactic factor for human mast cells. , 1994, Journal of immunology.
[14] L. Ashman,et al. Comparative cytokine release from human monocytes, monocyte-derived immature mast cells, and a human mast cell line (HMC-1). , 1994, The Journal of investigative dermatology.
[15] L. Ashman,et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. , 1993, The Journal of clinical investigation.
[16] D. Schadendorf,et al. Human mast cells produce IL-8. , 1993, Journal of immunology.
[17] D. Williams,et al. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. , 1993, The New England journal of medicine.
[18] B. Calabretta,et al. Role of the KIT protooncogene in normal and malignant human hematopoiesis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Kochan,et al. High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. , 1991, The Journal of biological chemistry.
[20] P. Leder,et al. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the SId mutant , 1991, Cell.
[21] G. Dewald,et al. Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.
[22] K. Kishi,et al. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. , 1985, Leukemia research.
[23] R. G. Ham,et al. Clonal growth of normal human epidermal keratinocytes in a defined medium , 1982, Journal of cellular physiology.